This is the authors' abstract. We don't add key points for this paper.
Rifampicin, a semisynthetic broad‐spectrum antibiotic with antibacterial activity for a variety of pathogenic microorganisms, has three crystal forms, namely, I, II, and SV. Forms I and II are bioavailable. Solid‐state polymorphic transformation (SST) from Form II to I and solution‐mediated polymorphic transformation (SMT) from Form I to II were investigated by offline X‐ray diffraction (PXRD) and Fourier transform infrared spectroscopy (FTIR), respectively. Solubility and supersolubility of rifampicin Forms I and II in different solvents were obtained using the static method and turbidity meter method separately. The thermodynamic study of rifampicin proved that crystal Form I was more stable than Form II. These studies were necessary to optimize the crystallization process and crystal form controlling. The bulk density which influences significantly the drug loading capacity was clearly developed.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Jing et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: